131 related articles for article (PubMed ID: 14656076)
1. Epigenetic silencing of the HIC-1 gene in human medulloblastomas.
Waha A; Waha A; Koch A; Meyer-Puttlitz B; Weggen S; Sörensen N; Tonn JC; Albrecht S; Goodyer CG; Berthold F; Wiestler OD; Pietsch T
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1192-201. PubMed ID: 14656076
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
[TBL] [Abstract][Full Text] [Related]
4. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
Chang Q; Ng HK
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Max-binding protein MNT in human medulloblastomas.
Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T
Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
Rood BR; Zhang H; Weitman DM; Cogen PH
Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas.
Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025
[TBL] [Abstract][Full Text] [Related]
11. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
Schüller U; Koch A; Hartmann W; Garrè ML; Goodyer CG; Cama A; Sörensen N; Wiestler OD; Pietsch T
Int J Cancer; 2005 Oct; 117(1):82-9. PubMed ID: 15880586
[TBL] [Abstract][Full Text] [Related]
12. SGNE1/7B2 is epigenetically altered and transcriptionally downregulated in human medulloblastomas.
Waha A; Koch A; Hartmann W; Milde U; Felsberg J; Hübner A; Mikeska T; Goodyer CG; Sörensen N; Lindberg I; Wiestler OD; Pietsch T; Waha A
Oncogene; 2007 Aug; 26(38):5662-8. PubMed ID: 17334394
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD
Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
[TBL] [Abstract][Full Text] [Related]
15. Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.
Anderton JA; Lindsey JC; Lusher ME; Gilbertson RJ; Bailey S; Ellison DW; Clifford SC
Neuro Oncol; 2008 Dec; 10(6):981-94. PubMed ID: 18664619
[TBL] [Abstract][Full Text] [Related]
16. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
[TBL] [Abstract][Full Text] [Related]
17. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer.
Tan LW; Bianco T; Dobrovic A
Carcinogenesis; 2002 Feb; 23(2):231-6. PubMed ID: 11872627
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.
Pietsch T; Waha A; Koch A; Kraus J; Albrecht S; Tonn J; Sörensen N; Berthold F; Henk B; Schmandt N; Wolf HK; von Deimling A; Wainwright B; Chenevix-Trench G; Wiestler OD; Wicking C
Cancer Res; 1997 Jun; 57(11):2085-8. PubMed ID: 9187099
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
